3h
Fin vs Fin on MSNZealthy vs Ro: Which Weight Loss Plan Works Best?Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...
As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them to severe eye conditions. In a new study published in the journal JAMA ...
Last year, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician.
17h
Pharmaceutical Technology on MSNAardvark prices $94.2m IPO to fund development of Prader-Willi syndrome drugAardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...
A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results